{"id":447055,"title":"Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-01-03","captureTimestamp":"2026-01-03T13:29:10.941000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/information-submission-requirements-biosimilar-biologic-drugs-1.html?wbdisable=false","snippet":"Guidance Document: Information and Submission Requirements for Biosimilar Biologic Drugs (PDF Version - 124 K) Date Adopted 2010/03/05 Revised Date 2016/11/14 Administrative Changes Date 2017-04-20 Revised Date 2022-08-26 Health Products and Food Branch Foreword Guidance…","rawSnapshotUrl":"/api/snapshots/raw/447055","browseUrl":"https://replay.healtharchive.ca/job-6/20260103132910/https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/information-submission-requirements-biosimilar-biologic-drugs-1.html?wbdisable=false#ha_snapshot=447055","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}